Earnings Releases & Investor Events
We interact with our shareholders and prospective investors through multiple channels. These include broker conferences, Alere-organized events, investor updates, and our Annual Report.
Details of the events we will be attending, as well as any information about events we are hosting, can be found here.
-
Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results
Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results -
30th Annual J.P. Morgan Healthcare Conference - January 11, 2012 - Investor Presentation
30th Annual J.P. Morgan Healthcare Conference - January 11, 2012 - Investor Presentation -
Webcast: 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012
Webcast: 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 -
Alere to Attend the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012
Alere to Attend the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 -
Alere to Attend the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference on December 6, 2011
Alere to Attend the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference on December 6, 2011 -
Alere to Attend 2011 Credit Suisse Annual Health Care Conference on November 9, 2011
Alere to Attend 2011 Credit Suisse Annual Health Care Conference on November 9, 2011 -
ALERE INC. ANNOUNCES Q3 2011 RESULTS
ALERE INC. ANNOUNCES Q3 2011 RESULTS -
Alere Q3-11 Earnings Call – Archive
Alere Q3-11 Earnings Call – Archive -
Alere Q3 2011 Earnings Conference Call Script
Alere Q3 2011 Earnings Conference Call Script -
Alere Inc. Schedules Conference Call for 8:30 a.m. ET October 26, 2011 to Discuss Third Quarter 2011 Results
Alere Inc. Schedules Conference Call for 8:30 a.m. ET October 26, 2011 to Discuss Third Quarter 2011 Results -
Alere to Attend the 2011 Morgan Stanley Global Healthcare Conference
September 13, 2011 -
Alere Q2 2011 Earnings Conference Call Script
Alere Q2 2011 Earnings Conference Call Script -
ALERE INC. ANNOUNCES Q2 2011 RESULTS
ALERE INC. ANNOUNCES Q2 2011 RESULTS -
Alere Inc. Schedules Conference Call for 8:30 a.m. ET July 27, 2011 to Discuss Second Quarter 2011 Results
Alere Inc. Schedules Conference Call for 8:30 a.m. ET July 27, 2011 to Discuss Second Quarter 2011 Results -
Alere to Attend the Goldman Sachs Leveraged Finance Healthcare Conference 2011 on March 8, 2011
Contact: Doug Guarino, Director of Corporate Relations 781 647 3900 -
Alere to Attend the Goldman Sachs 32nd Annual Global Health Care Conference on June 7, 2011
WALTHAM, Mass., May 31, 2011 -
Alere Q1 2011 Earnings Conference Call Script (updated 29 April 2011)
Alere Q1 2011 Earnings Conference Call Script (updated 29 April 2011) -
ALERE INC. ANNOUNCES Q1 2011 RESULTS
ALERE INC. ANNOUNCES Q1 2011 RESULTS -
Alere Inc. Schedules Conference Call for 8:30 a.m. ET April 27, 2011 to Discuss First Quarter 2011 Results
Alere Inc. Schedules Conference Call for 8:30 a.m. ET April 27, 2011 to Discuss First Quarter 2011 Results -
Alere to Attend the Citi 2011 Global Health Care Conference on March 2, 2011
FOR IMMEDIATE RELEASE -
ALERE INC. ANNOUNCES Q4 2010 RESULTS
ALERE INC. ANNOUNCES Q4 2010 RESULTS -
Alere Q4 2010 Earnings Conference Call Script
Alere Q4 2010 Earnings Conference Call Script -
Alere Inc. Schedules Conference Call for 8:00 a.m. ET February 17, 2011 to Discuss Fourth Quarter 2010 Results
Alere Inc. Schedules Conference Call for 8:00 a.m. ET February 17, 2011 to Discuss Fourth Quarter 2010 Results -
Alere Q3 2010 Earnings Conference Call Script
Alere Q3 2010 Earnings Conference Call Script -
ALERE INC. ANNOUNCES THIRD QUARTER 2010 RESULTS
ALERE INC. ANNOUNCES THIRD QUARTER 2010 RESULTS -
Alere Inc. Schedules Conference Call for 10:00 a.m. ET November 1, 2010 to Discuss Third Quarter 2010 Results
Alere Inc. Schedules Conference Call for 10:00 a.m. ET November 1, 2010 to Discuss Third Quarter 2010 Results -
ALERE INC. ANNOUNCES SECOND QUARTER 2010 RESULTS
ALERE INC. ANNOUNCES SECOND QUARTER 2010 RESULTS -
Inverness Medical Innovations Announces First Quarter 2010 Results
Inverness Medical Innovations Announces First Quarter 2010 Results -
Inverness Medical Innovations Announces Fourth Quarter 2009 Results
Inverness Medical Innovations Announces Fourth Quarter 2009 Results -
Inverness Medical Innovations Announces Third Quarter 2009 Results
Inverness Medical Innovations Announces Third Quarter 2009 Results -
Inverness Medical Innovations Announces Second Quarter 2009 Results
Inverness Medical Innovations Announces Second Quarter 2009 Results -
Inverness Medical Innovations Announces First Quarter 2009 Results
Inverness Medical Innovations Announces First Quarter 2009 Results -
Inverness Medical Innovations Announces Fourth Quarter 2008 Results
Inverness Medical Innovations Announces Fourth Quarter 2008 Results -
Inverness Medical Innovations Announces Third Quarter 2008 Results
Inverness Medical Innovations Announces Third Quarter 2008 Results -
Inverness Medical Innovations Announces Second Quarter 2008 Results
Inverness Medical Innovations Announces Second Quarter 2008 Results -
Inverness Medical Innovations Announces First Quarter 2008 Results
Inverness Medical Innovations Announces First Quarter 2008 Results
Since its discovery in 1981, HIV has become a global pandemic, with over thirty-three million cases worldwide and more than 2.5 million new cases occurring each year. And, while these figures are staggering, a host of technological advances and scientific breakthroughs have helped make living with HIV more manageable. Alere has been at the forefront of many of these advances, working to provide tools that enable healthcare practitioners to detect the virus and make more informed decisions about the appropriate therapy for diagnosed individuals earlier. The Alere Pima™ CD4 Analyzer, which provides absolute CD4 results in 20 minutes, has been shown to improve access to critical data and decrease the time to antiretroviral therapy initiation in remote corners of the world.